CEOs of the biggest AI companies have predicted the technology will “eliminate most cancer” and “improve treatment of most ...
The goal should not be to reproduce today’s health care system with fewer humans,” writes American Medical Association CEO ...
Autonomous AI will likely soon exceed both unaided physicians and physicians aided by AI at five core cognitive medical tasks ...
WASHINGTON — The Trump administration permanently filled four key leadership roles at the Food and Drug Administration on ...
An experimental COPD drug from AstraZeneca could prove competitive with existing treatments, and have a slice of the market ...
Roivant said Tuesday an experimental drug for a type of pulmonary hypertension achieved the goals of a mid-stage study — ...
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...
Roivant drug delivers mid-stage results, Moonwalk raises funds to develop longer-lasting obesity drugs, and more biotech news ...
An experimental Novartis drug for a rare neuromuscular condition failed to improve muscle function in a pivotal study ...
In health tech news today, Oura reports a profit, the FDA loses another key digital health leader, and more ...
The FDA warned a supplier of active pharma ingredients about residue on walls, a corroded product line, and open-toed sandals ...
A Novartis drug for a rare neuromuscular condition failed in a key study, the company's second major trial collapse in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results